Analytical validation of anti-toxoplasma IgG immunoassays

AUTOR(ES)

Souza, Guenael Freire de, Carvalho, Darlene, Pedrosa, William, Franck, Jacqueline, Piarroux, Renaud

FONTE

Braz J Infect Dis

DATA DE PUBLICAÇÃO

2012-12

RESUMO

There are often discrepancies when using different methods to measure anti-Toxoplasma gondii IgG levels in patient samples. The diagnostic performance of a chemiluminescent immunoassay (CLIA) and an enzyme-linked fluorescent assay (ELFA) used as confirmatory tests for samples identified as positive or equivocal by an electrochemiluminescent immunoassay (ECLIA) were examined. Cut-off values were those stated by the manufacturer, and Western blot was used to confirm the results of all methods. All samples identified as positive by ECLIA (n = 93) were confirmed as positive by Western blot, as were 14 of the 28 samples identified as equivocal. When these 121 samples were retested, the sensitivities of CLIA and ELFA were 64.4% and 73.8%, respectively. Both methods exhibited a specificity of 100%. This study confirms that the results obtained from the different immunoassays are not comparable, and neither CLIA nor ELFA should be used to confirm ECLIA results, which should instead be confirmed by methods such as Western blot or Sabin-Feldman dye test.

Documentos Relacionados

• RESEARCH OF IgG ANTI-Toxoplasma gondii IN EXUDATE MEAT JUICE FOR MONITORING THE CATTLE BEEF QUALITY
• Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.
• Avaliação da técnica de ELISA para pesquisa de IgG anti-Toxoplasma gondii em exsudatos de carnes de sol
• Freqüência de anticorpos IgG anti-Toxoplasma gondii em soros de cães errantes da cidade de Salvador-Bahia, Brasil
• Ocorrência de anticorpos IgG anti-Neospora caninum e anti-Toxoplasma gondii em caprinos e ovinos do oeste do Maranhão, Brasil